Cutaneous chemical carcinogenesis: past, present, and future.
Skin tumors chemically induced in mice have provided an important experimental model for studying carcinogenesis and for bioassaying carcinogenic agents. The information obtained from this model suggests that the events leading to tumor formation can be divided into at least two stages, initiation and promotion. A single small dose of carinogen produces initiation which appears to be irreversible. These initiating agents may have to be metabolically activated and can interact with cellular macromolecules. The extent to which they bind to DNA correlates well with their carcinogenicity. Increased DNA replication at the time of or during the first day after these agents have been applied appears to enhance carcinogenesis. Unlike initiation, promotion appears to be reversible and the promoting agents must be applied repeatedly before tumors are formed. Promoters interact with membranes, stimulate and alter genetic expression, and increase the rate of cell proliferation. The knowledge gained from these studies in mouse skin has immeasurably helped the entire field of chemical carcinogenesis. But efforts to determine the cellular and molecular mechanisms involved in the carcinogenic process, particularly in the skin, have been hampered by the difficulties of working on whole animals and by the special problems associated with the biologic and biochemical methods required for this target organ. Such problems, however, can be solved by the use of cell cultures of mouse epidermis which can metabolize and bind carcinogens just as is done in vivo. The fact that epidermal cells in vitro proliferate synchronously should facilitate the study of the relation between the cell cycle and carcinogenesis. These cells repair chemically induced DNA damage by at least two mechanisms, excision repair and base-specific repair. When epidermal cells in vitro are exposed to promoting agents, a proliferative response analogous to that in vivo is elicited, apparently mediated through control of polyamine metabolism. Neoplastic transformation has been induced in these cultures by known skin carcinogens.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000009:adverse effects; D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000009:adverse effects; D001580:Benzopyrenes / Q000009:adverse effects; D002273:Carcinogens / Q000009:adverse effects*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002621:Chemistry; D003436:Croton Oil / Q000009:adverse effects; D003470:Culture Media; D004273:DNA, Neoplasm / Q000378:metabolism; D004195:Disease Models, Animal; D004357:Drug Synergism; D007700:Kinetics; D008769:Methylnitronitrosoguanidine / Q000009:adverse effects; D051379:Mice; D009955:Ornithine Decarboxylase / Q000378:metabolism; D012334:RNA, Neoplasm / Q000378:metabolism; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000235:genetics
D001580:Benzopyrenes; D002273:Carcinogens; D003470:Culture Media; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D008769:Methylnitronitrosoguanidine; D015127:9,10-Dimethyl-1,2-benzanthracene; D003436:Croton Oil; D001189:Aryl Hydrocarbon Hydroxylases; D009955:Ornithine Decarboxylase